PubMed Health⌕ Search

Biomedical subjects

W E Brenner

Publications and source records attributed to W E Brenner.

At least 19 recordsLinked to original sources

Metronidazole-containing vaginal sponges for the treatment of bacterial vaginosis.

Currently, there is no FDA approved treatment for bacterial vaginosis (BV), although various oral dosages of metronidazole are used to treat this condition. A vaginal therapeutic sponge (VLI Corporation) that releases metronidazole over a 24 h use period has been developed for the treatment of BV. Each sponge contains 250 mg of metronidazole. The safety and effectiveness of using one or three metronidazole-containing vaginal sponges for the treatment of BV was evaluated in 40 patients. Use of a single sponge resulted in a cure rate of 38.9%. With three sponges the cure rate was 94.4%. Cure was defined as the absence of signs and symptoms (vaginal discharge, elevated pH, KOH prep odor, and 'clue' cells) at the one and four week follow-up visits. The sexual partners of most women were also treated with metronidazole (2 g po in one dose). None of the women were discontinued from treatment because of any adverse effects. Side-effects were minimal and required no treatment. The cure rate with the three vaginal sponge dosage appears to be similar to that associated with oral dosages of metronidazole.

Administration, Intravaginal↗

Pregnancy-induced hypertension presenting with life-threatening thrombocytopenia.

Three cases of pregnancy-induced hypertension in which patients presented with platelet counts of less than 20,000/mm3 are reported. None of the patients had severe hypertension. The need for an immediate platelet count for any gravid patient with suspected pregnancy-induced hypertension is emphasized. Management of patients with pregnancy-induced hypertension and thrombocytopenia is reviewed. Prompt delivery appears to be necessary because no other therapy reverses this disease process. Patients with pregnancy-induced hypertension and thrombocytopenia should be classified as having "severe preeclampsia" irrespective of other signs or symptoms of "severe preeclampsia."

Adult↗

Improving survival with liver rupture complicating pregnancy.

The reported maternal mortality of 59% that results from rupture of the liver in pregnancy is probably excessive if modern diagnostic and treatment techniques are fully utilized. The rarity and variable presentation should not lead to an incorrect diagnosis and possible fatal outcome. Pregnant patients or patients who recently have undergone delivery, especially those with hypertension, who complain of epigastric and/or discomfort in the right upper quadrant of the abdomen should be considered to be candidates for rupture of the liver. Ultrasound, which is generally available, is an adequate diagnostic technique in most patients. Computed tomography and technetium scanning are helpful tools. Ligation of specific bleeding points, compression, deep hepatic sutures, omental pedicles, topical agents, ligation of the hepatic artery, hepatic artery embolization, and other techniques should be used prior to performance of lobectomy. Drainage is recommended. Replacement of blood, correction of coagulation defects, monitoring of respiratory function, and attention to known postoperative complications should improve the outcome of patients with this serious complication.

Adult↗

Evaluation of contemporary female sterilization methods.

Different methods of sterilization were evaluated. Laparoscopic techniques were the most satisfactory because they had lower pelvic and incision infection rates and shorter hospitalization and convalescent times than laparotomy lower pelvic infection rates than culdoscopy and culpotomy. Via laparoscopy, sterilization by coagulation and cutting, spring-loaded clips and bands was an effective, safe method. Mechanical problems with the applicator and optics and decreased visibility resulted in more technical failures and difficulties and more misapplication with the clip applicator. Although the total complication rates were similar with all methods, bleeding from the tubes and wound and pelvic infections were more frequent with silastic-band technique. Long-term complications, such as dysmenorrhea and menometrorrhagia and especially those resulting in hysterectomy after laparoscopy, are infrequent. Pregnancy rates are low after laparoscopic sterilization with coagulation and silastic bands as compared to the clip. Rates of complications with sterilization combined with abortion or delivery are only slightly higher than after abortion without sterilization and much less than the combined complications that would be anticipated from abortion and interval sterilization. To make colpotomy, culdoscopy and minilaparotomy easier and potentially safer, mechanical techniques using the spring-loaded clip and silastic band are being evaluated. Simplified techniques that can be administered via the cervix, such as Quinacrine, may be practical in the future.

Abortion, Induced↗

Termination of pregnancy complicated by anencephaly with intra-amniotic prostaglandin F2 alpha.

It is anticipated that there will be more frequent need to terminate anencephalic pregnancies of greater than 20 weeks' duration before term. Since present methods are unsatisfactory, the use of incremental intra-amniotic injections of prostaglandin F2 alpha with continuous monitoring of intrauterine pressure was evaluated in three cases. The method appears to be satisfactory.

Abortion, Induced↗

Characteristics of patients with placenta previa and results of "expectant management".

To determine the differences between pregnancies complicated by placenta previa and those without placenta previa, the characteristics of 31,070 consecutive deliveries at one institution were analyzed. The philosophy of "expectant management" of the premature fetus and frequent use of cesarean section was utilized in the 185 patients with placenta previa. A higher proportion of these patients were multiparous, were older, had had previous abortions, and were carrying a male fetus or twins. The fetal and placental weights in these patients were similar to those in other patients throughout pregnancy. Rates of prematurity, antepartum and intrapartum fetal death, neonatal death, congenital abnormality, and low Apgar scores were higher among patients with placenta previa. Data were compiled in a manner that allows the obstetrician to: (1) evaluate the fetal weight and expected fetal growth; (2) estimate the probability that his patient will deliver prematurely and will deliver within the next one-, two-, or four-week interval; (3) determine the relative risks to the fetus prior to labor, during labor, and in the neonatal period at each stage of gestation.

Apgar Score↗

The obfuscation of eclampsia by thrombotic thrombocytopenic purpura.

All case reports of TTP in pregnancy were reviewed. In some cases the primary diagnosis of TTP may have been inappropriate, with severe pre-eclampsia or eclampsia being the primary problem. Some cases of eclampsia and severe pre-eclampsia satisfy all the criteria for the diagnosis of TTP syndrome. However, the prognosis is much better and management of these patients is very different from the nonpregnant patient with the TTP syndrome. The use of the term TTP syndrome to describe these patients may be confusing. Two cases of eclampsia are presented where the diagnosis of TTP could have been made but would have been inappropriate.

Adolescent↗

Catecholamines during therapeutic abortion induced with intra-amniotic prostaglandin F2alpha.

Serial plasma, amniotic fluid, and urine samples were analyzed for epinephrine (E) and norepinephrine (NE) in eight subjects during midtrimester abortion induced by intra-amniotic prostaglandin F2alpha (PGF2alpha). After PGF2alpha administration, plasma E increased and there was no change in plasma NE levels. Amniotic fluid levels of E and NE decreased initially. During the course of abortion the mean level of E in the amniotic fluid increased after fetal distress and decreased after fetal death, indicating that the midtrimester fetus of both E and NE increased following PGF2alpha. The observation that mean plasma levels and urinary excretion rate changes correlated better with the course of abortion and uterine contractility rather than with the time of PGF2alpha administration was consistent with the hypothesis that the catecholamine response may be due to the stress of labor rather than to the PGF2alpha per se.

Abortion, Therapeutic↗

Arachidonic acid and other free fatty acid changes during abortion induced by prostaglandin F2alpha.

Serum free fatty acids (FFA's) were measured after intra-amniotic injection of prostaglandin F2alpha (PGF2alpha) for the induction of abortion in eight healthy women in the midtrimester of pregnancy. The total FFA levels increased in all cases during the period between PGF2alpha administration and abortion. This lipolysis most likely is secondary to the effect of the catecholamines as indicated by the temporal relationship between increased plasma and urine catecholamine and serum FFA levels. The percentage of arachidonic acid in the total amount of FFA's decreased after administration of PGF2alpha. This proportional decrease in arachidonic acid (p less than 0.05) may be due to selective utilization for the production of endogenous prostaglandins.

Abortion, Induced↗

Clostridial sepsis after abortion with PGF2alpha and intracervical laminaria tents--a case report.

A case of clostridial endomyometritis and sepsis necessitating total abdominal hysterectomy which occurred 12 hours following abortion induced with intraamniotic administration of prostaglandin F2 alpha and laminaria tent insertion is discussed. Cultures from cervical, blood, and surgical specimens all yielded Clostridium perfringens. Intrauterine contamination with this microorganism most likely followed the insertion of laminaria tents through the cervical os, which was colonized with C. perfringens. Since C. perfringens may be present in the microflora of the lower female genital tract, great care must be taken to cleanse this area prior to intracervical laminaria tent insertion.

Abortion, Induced↗

The thermogenic activity of exogenous E and F prostaglandins in humans.

A basic understanding of the physiologic effects of the prostaglandins on the human reproductive system has been one of the diverse scientific interests of Professor Axel Ingelman-Sundberg (19). Although the obvious clinical ultility of these ubiqitous compounds directed early attention to their therapeutic aspects, more recently there has been renewed interest in the basic physiologic mechanisms of the prostaglandins in reproductive medicine. Undoubtedly, the work of Dr Ingelman-Sundberg has stimulated many of his colleagues, students, and fellow scientists to pursue such basic studies in greater details.

Abortion, Induced↗

Menstrual regulation: risks and "abuses".

The definitions, methods, and techniques of menstrual regulation (MR) are presented. The risks and abuses of performing MR by vacuum aspiration to terminate pregnancies of less than 7 menstrual weeks are reviewed.

Abortion, Induced↗

A standard of fetal growth for the United States of America.

The appropriate interpretation of monitored fetal growth throughout pregnancy in individual patients and populations is dependent upon the availability of adequate standards. There is no adequate standard of fetal weight throughout pregnancy that is suitable for patients in the U.S.A. To determine such a standard for infants delivered at about sea level the 10th, 25th, 50th, 75th, and 90th percentiles of fetal weight for each menstrual week of gestation were calculated from 430 fetuses at 8 to 20 menstrual weeks' gestation aborted with prostaglandins and from 30,772 liveborn infants delivered of patients at 21 to 44 menstrual weeks' gestation. Median fetal crown-to-rump lengths and crown-to-heel lengths were derived from measurements of 496 aborted fetuses of 8 to 21 weeks' gestation. Fetal weight correction factors for parity, race (socioeconomic status), and fetal sex were calculated. The derived fetal growth curves are useful for clinical, public health, and investigational purposes.

Body Height↗